IL23A and psoriasis: Despite the complex pathogenesis of psoriasis, it is well-established that the IL-23/Th17 cell axis plays a critical role in disease development, forming the foundation for the targeted biologic treatments of psoriasis used in clinical practice (Gaffen et al., 2014; Nakajima, 2012).